High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes
…, S Mahendru, A Krishnamurthy, A Dewan… - Diabetes & Metabolic …, 2021 - Elsevier
Background and aims To study the prevalence and impact of diabetes mellitus and other
comorbidities among hospitalized patients with COVID-19. Methods In a prospective, …
comorbidities among hospitalized patients with COVID-19. Methods In a prospective, …
[HTML][HTML] Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19
…, R Sharma, KJ Farooqui, S Mahendru, A Dewan… - Scientific reports, 2021 - nature.com
Vitamin D deficiency (VDD) owing to its immunomodulatory effects is believed to influence
outcomes in COVID-19. We conducted a prospective, observational study of patients, …
outcomes in COVID-19. We conducted a prospective, observational study of patients, …
[HTML][HTML] Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study
R Aggarwal, A Dewan - Annals of clinical microbiology and antimicrobials, 2018 - Springer
Background The most important concern with polymyxins (Colistin and Polymyxin B) use is
nephrotoxicity. There is no prospective data comparing nephrotoxicity of these two drugs, …
nephrotoxicity. There is no prospective data comparing nephrotoxicity of these two drugs, …
Differentials in the characteristics of COVID-19 cases in Wave-1 and Wave-2 admitted to a network of hospitals in North India
…, O Singh, N Singh, A Kumar, P Saxena, A Dewan… - MedRxiv, 2021 - medrxiv.org
Second wave of COVID-19 pandemic in India came with unexpected quick speed and
intensity, creating an acute shortage of beds, ventilators, and oxygen at the peak of occurrence. …
intensity, creating an acute shortage of beds, ventilators, and oxygen at the peak of occurrence. …
Effectiveness of convalescent plasma in Indian patients with COVID-19
S Budhiraja, A Dewan, R Aggarwal, O Singh… - Blood Cells, Molecules …, 2021 - Elsevier
Background Convalescent plasma (CP) is being used as a treatment option in hospitalized
patients with COVID-19. Till date, there is conflicting evidence on efficacy of CP in reducing …
patients with COVID-19. Till date, there is conflicting evidence on efficacy of CP in reducing …
[HTML][HTML] Respiratory co-infections: modulators of SARS-CoV-2 patients' clinical sub-phenotype
…, PP Hazarika, S Wadhwa, N Tyagi, A Dewan… - Frontiers in …, 2021 - frontiersin.org
Co-infection with ancillary pathogens is a significant modulator of morbidity and mortality in
infectious diseases. There have been limited reports of co-infections accompanying SARS-…
infectious diseases. There have been limited reports of co-infections accompanying SARS-…
Clinical Profile of First 1000 COVID-19 cases admitted at tertiary care hospitals and the correlates of their mortality: an Indian experience
S Budhiraja, A Soni, V Jha, A Indrayan, A Dewan… - MedRxiv, 2020 - medrxiv.org
Objective To describe the clinical profile and factors leading to increased mortality in coronavirus
disease (COVID-19) patients admitted to a group of hospitals in India. Design A records…
disease (COVID-19) patients admitted to a group of hospitals in India. Design A records…
Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: a retrospective cohort study
R Aggarwal, A Dewan, A Pandey, N Trehan… - International …, 2022 - Elsevier
Background Various immunomodulatory therapies have been explored to manage the
dysregulated immune response seen in severe COVID-19 infection. The objective of this study …
dysregulated immune response seen in severe COVID-19 infection. The objective of this study …
[HTML][HTML] COVID-19 Risk Stratification and Mortality Prediction in Hospitalized Indian Patients: Harnessing clinical data for public health benefits
…, PP Hazarik, P Das, S Budhiraja, V Nangia, A Dewan… - PLoS …, 2022 - journals.plos.org
The variability of clinical course and prognosis of COVID-19 highlights the necessity of patient
sub-group risk stratification based on clinical data. In this study, clinical data from a cohort …
sub-group risk stratification based on clinical data. In this study, clinical data from a cohort …
[HTML][HTML] Low FT3 is an independent marker of disease severity in patients hospitalized for COVID-19
…, KJ Farooqui, S Mahendru, A Dewan… - Endocrine …, 2021 - ec.bioscientifica.com
Aim To study the prevalence of thyroid dysfunction and its association with disease severity
in hospitalized patients of coronavirus disease-19 (COVID-19). Methods In this retrospective …
in hospitalized patients of coronavirus disease-19 (COVID-19). Methods In this retrospective …